(Q47933206)

English

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, plac

scientific article published on 26 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

based on heuristic

inferred from title

atopic dermatitis

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Kenji Kabashima

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

O Nemoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Furue

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H Nakagawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Shiramoto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

R Hanada

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S Matsuki

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S Imayama

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Kato

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

I Hasebe

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

K Taira

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M Yamamoto

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

R Mihara

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

T Ruzicka

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J Hanifin

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Y Kumagai

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

0 references

publication date

19 December 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

174

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

296-304

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

What causes itch in atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Systemic therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

IL-31: a new link between T cells and pruritus in atopic skin inflammation

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Validation of actigraphy for determining sleep and wake in children with sleep disordered breathing.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Muscular exercise can cause highly pathological liver function tests in healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Ethnic sensitivity assessment - pharmacokinetic comparability between Japanese and non-Japanese healthy subjects on selected mAbs

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

A comparison of radio-frequency biomotion sensors and actigraphy versus polysomnography for the assessment of sleep in normal subjects.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Health-related quality of life in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.14207

21 January 2018

Identifiers

10.1111/BJD.14207

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26409172%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47933206&oldid=1543948747"